ARTICLE | Company News
Immunomedics other research news
August 9, 1993 7:00 AM UTC
IMMU received a Phase I $50,000 SBIR grant from the National Cancer Institute to engineer a humanized antibody to treat breast cancer. IMMU said its goal is to develop a humanized antibody that could ...